These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1205 related articles for article (PubMed ID: 10053096)
1. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096 [TBL] [Abstract][Full Text] [Related]
2. [Treatment and prognostic factors for stage IV epithelial ovarian cancer]. Wu M; Shen K; Lang J Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):200-3. PubMed ID: 11776158 [TBL] [Abstract][Full Text] [Related]
3. Cytoreductive surgery for stage IV epithelial ovarian cancer. Zang RY; Zhang ZY; Cai SM; Li ZT; Chen J; Tang MQ; Liu Q J Exp Clin Cancer Res; 1999 Dec; 18(4):449-54. PubMed ID: 10746968 [TBL] [Abstract][Full Text] [Related]
4. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP; J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437 [TBL] [Abstract][Full Text] [Related]
6. The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma. Bristow RE; Duska LR; Montz FJ Gynecol Oncol; 2001 Apr; 81(1):92-9. PubMed ID: 11277657 [TBL] [Abstract][Full Text] [Related]
7. Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator. Bristow RE; Montz FJ Gynecol Oncol; 2001 Oct; 83(1):39-48. PubMed ID: 11585412 [TBL] [Abstract][Full Text] [Related]
8. Optimal cytoreductive surgery is an independent prognostic indicator in stage IV epithelial ovarian cancer with hepatic metastases. Naik R; Nordin A; Cross PA; Hemming D; de Barros Lopes A; Monaghan JM Gynecol Oncol; 2000 Aug; 78(2):171-5. PubMed ID: 10926798 [TBL] [Abstract][Full Text] [Related]
9. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277 [TBL] [Abstract][Full Text] [Related]
10. Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival. Bristow RE; Zerbe MJ; Rosenshein NB; Grumbine FC; Montz FJ Gynecol Oncol; 2000 Aug; 78(2):85-91. PubMed ID: 10926785 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer. Munkarah AR; Hallum AV; Morris M; Burke TW; Levenback C; Atkinson EN; Wharton JT; Gershenson DM Gynecol Oncol; 1997 Jan; 64(1):13-7. PubMed ID: 8995541 [TBL] [Abstract][Full Text] [Related]
12. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Eisenkop SM; Friedman RL; Wang HJ Gynecol Oncol; 1998 May; 69(2):103-8. PubMed ID: 9600815 [TBL] [Abstract][Full Text] [Related]
13. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis. Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126 [TBL] [Abstract][Full Text] [Related]
14. The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma. Eitan R; Levine DA; Abu-Rustum N; Sonoda Y; Huh JN; Franklin CC; Stevens TA; Barakat RR; Chi DS Cancer; 2005 Apr; 103(7):1397-401. PubMed ID: 15726548 [TBL] [Abstract][Full Text] [Related]
15. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer. Zang RY; Zhang ZY; Li ZT; Cai SM; Tang MQ; Chen J; Liu Q Eur J Surg Oncol; 2000 Dec; 26(8):798-804. PubMed ID: 11087649 [TBL] [Abstract][Full Text] [Related]
16. Effect of surgical debulking on survival in stage IV ovarian cancer. Liu PC; Benjamin I; Morgan MA; King SA; Mikuta JJ; Rubin SC Gynecol Oncol; 1997 Jan; 64(1):4-8. PubMed ID: 8995539 [TBL] [Abstract][Full Text] [Related]
18. [Cytoreductive surgery in the management of stage IV epithelial ovarian cancer]. Zang R; Zhang Z; Chen J Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):197-9. PubMed ID: 11776157 [TBL] [Abstract][Full Text] [Related]
19. Primary ovarian sarcoma: analysis of prognostic variables and the role of surgical cytoreduction. Sood AK; Sorosky JI; Gelder MS; Buller RE; Anderson B; Wilkinson EJ; Benda JA; Morgan LS Cancer; 1998 May; 82(9):1731-7. PubMed ID: 9576296 [TBL] [Abstract][Full Text] [Related]
20. The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer. Lim MC; Kang S; Lee KS; Han SS; Park SJ; Seo SS; Park SY Gynecol Oncol; 2009 Jan; 112(1):28-34. PubMed ID: 19010521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]